Your browser doesn't support javascript.
loading
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.
Dillinger, Thomas; Sheibani-Tezerji, Raheleh; Pulverer, Walter; Stelzer, Ines; Hassler, Melanie R; Scheibelreiter, Janine; Pérez Malla, Carlos Uziel; Kuroll, Madeleine; Domazet, Sandra; Redl, Elisa; Ely, Sarah; Brezina, Stefanie; Tiefenbacher, Andreas; Rebhan, Katharina; Hübner, Nicolai; Grubmüller, Bernhard; Mitterhauser, Markus; Hacker, Marcus; Weinhaeusel, Andreas; Simon, Judit; Zeitlinger, Markus; Gsur, Andrea; Kramer, Gero; Shariat, Shahrokh F; Kenner, Lukas; Egger, Gerda.
Afiliação
  • Dillinger T; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Sheibani-Tezerji R; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Pulverer W; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Stelzer I; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Hassler MR; Health & Environment Department, Molecular Diagnostics, AIT-Austrian Institute of Technology GmbH, Vienna, Austria.
  • Scheibelreiter J; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Pérez Malla CU; Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria.
  • Kuroll M; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Domazet S; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Redl E; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Ely S; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Brezina S; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Tiefenbacher A; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Rebhan K; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Hübner N; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Grubmüller B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Mitterhauser M; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Hacker M; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Weinhaeusel A; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Simon J; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Zeitlinger M; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Gsur A; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Kramer G; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Shariat SF; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria.
  • Kenner L; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria.
  • Egger G; Health & Environment Department, Molecular Diagnostics, AIT-Austrian Institute of Technology GmbH, Vienna, Austria.
Mol Cancer ; 21(1): 7, 2022 01 03.
Article em En | MEDLINE | ID: mdl-34980142
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Metilação de DNA / Neoplasias de Próstata Resistentes à Castração / Biópsia Líquida Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Metilação de DNA / Neoplasias de Próstata Resistentes à Castração / Biópsia Líquida Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria